QuidelOrtho Corp. Stock
Price
Target price
€36.80
€36.80
-0.540%
-0.2
-0.540%
€75.48
22.04.24 / Tradegate
WKN: A3DNGX / Symbol: QDEL / Name: QuidelOrtho / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
QuidelOrtho Corp. Stock
QuidelOrtho Corp. shows a slight decrease today, losing -€0.200 (-0.540%) compared to yesterday.
We see a rather positive sentiment for QuidelOrtho Corp. with 6 Buy predictions and 2 Sell predictions.
With a target price of 75 € there is potential for a 103.8% increase which would mean more than doubling the current price of 36.8 € for QuidelOrtho Corp..
Our community identified positive and negative aspects for QuidelOrtho Corp. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the QuidelOrtho Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | -0.540% | 1.099% | -15.596% | -55.416% | -45.739% | -61.619% | - |
| Boston Scientific | 6.200% | 7.031% | 9.460% | 47.344% | 33.165% | 93.996% | 119.165% |
| Illumina Inc. | -1.620% | 3.518% | -9.794% | -44.681% | -10.693% | -66.533% | -59.305% |
| Waters Corp. | 0.750% | -3.592% | -9.969% | 2.801% | -4.007% | 14.134% | 55.726% |
Comments
QuidelOrtho Co. (NASDAQ: QDEL) had its "sell" rating re-affirmed by analysts at UBS Group AG. They now have a $42.00 price target on the stock, down previously from $70.00.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) had its price target lowered by analysts at Royal Bank of Canada from $130.00 to $81.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $37.00 price target on the stock, down previously from $66.00.
Show more
Ratings data for QDEL provided by MarketBeat
News
QuidelOrtho To Report First Quarter 2024 Financial Results
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
QuidelOrtho Corporation (Nasdaq: QDEL) has added the ARK™ Fentanyl II Assay to its U.S. Vitros® XT 7600 and 5600 Integrated Systems as well as its Vitros® 4600 Chemistry System menu of assays as a
QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho" or the “Company”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its QuickVue COVID-19 test. This clearance allows